{
  "retracted": false,
  "timestamp": 1539302400000,
  "updates": [
    {
      "timestamp": 1570839137358,
      "identifier": {
        "doi": "10.1007/s40267-018-0567-2"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40267-018-0539-6"
  },
  "journal": "Drugs & Therapy Perspectives",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use"
}
